| Serial Number | 90127831 |
| Word Mark | KINNATE |
| Filing Date | Thursday, August 20, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 18, 2021 |
| Goods and Services | therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; antibacterial pharmaceuticals; pharmaceutical preparations for the prevention and treatment of allergies |
| Goods and Services | scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 24, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 24, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kinnate Biopharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94129 |
| Party Name | Kinnate Biopharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Monday, March 18, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 18, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, February 6, 2024 | WITHDRAWAL OF ATTORNEY GRANTED |
| Tuesday, February 6, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Thursday, June 1, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 30, 2023 | SOU EXTENSION 3 GRANTED |
| Tuesday, May 30, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, May 30, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 16, 2022 | SOU EXTENSION 2 GRANTED |
| Friday, December 16, 2022 | SOU EXTENSION 2 FILED |
| Friday, December 16, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 18, 2022 | SOU EXTENSION 1 GRANTED |
| Monday, July 18, 2022 | SOU EXTENSION 1 FILED |
| Monday, July 18, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 19, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, July 19, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 19, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, February 15, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, December 30, 2021 | TTAB RELEASE CASE TO TRADEMARKS |
| Thursday, December 30, 2021 | OPPOSITION TERMINATED NO. 999999 |
| Thursday, December 30, 2021 | OPPOSITION DISMISSED NO. 999999 |
| Monday, November 15, 2021 | OPPOSITION INSTITUTED NO. 999999 |
| Tuesday, September 28, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, September 28, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 28, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, June 10, 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, May 18, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 18, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, April 15, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 12, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 12, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, December 29, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 29, 2020 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 29, 2020 | SUSPENSION LETTER WRITTEN |
| Wednesday, December 16, 2020 | ASSIGNED TO EXAMINER |
| Thursday, September 24, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 24, 2020 | NEW APPLICATION ENTERED |